Table 1.
Subject number | AIS | Injury level | Time pass onset | FIM motor | WISCI | SCIM-III |
Similarity index |
Magnitude |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Self care | Mobility | Total | Mean upper SI | Mean lower SI | Mean upper and lower SI | Mean upper Mag | Mean lower Mag | Mean upper and lower Mag | ||||||
1 | A | T8 | 9 days | 18 | 0 | 4 | 0 | 14 | NT | 0.00 | NT | NT | 0 | NT |
2 | A | C8 | 19 days | 16 | 0 | 6 | 2 | 25 | NT | 0.00 | NT | NT | 0 | NT |
3 | D | C8 | 3 days | 69 | 8 | 13 | 25 | 77 | 0.57 | 0.88 | 0.72 | 47 | 57 | 52 |
4 | D | C6 | 4 days | 24 | 8 | 12 | 18 | 70 | 0.84 | 0.94 | 0.89 | 48 | 137 | 93 |
5 | D | C6 | 5 days | 21 | 0 | 0 | 6 | 36 | 0.87 | 0.88 | 0.88 | 47 | 101 | 74 |
6 | D | C6 | 10 days (B) | 58 | 17 | 8 | 22 | 67 | 0.91 | 0.95 | 0.93 | 84 | 61 | 73 |
7 | A | T9 | 4 months | 52 | 0 | 14 | 15 | 59 | NT | 0.00 | NT | NT | 0 | NT |
8 | A | C5 | 5 months | 14 | 0 | 0 | 3 | 13 | 0.33 | 0.00 | 0.17 | 29 | 0 | 15 |
1f | A | T5 | 5 months | 18 | 0 | 4 | 0 | 14 | NT | 0.00 | NT | NT | 0 | NT |
9 | C | C4 | 48 days | 22 | 17 | 6 | 19 | 56 | 0.46 | 0.89 | 0.68 | 24 | 44 | 34 |
10 | D | C4 | 3 months | 91 | 20 | 19 | 40 | 99 | 0.85 | 0.88 | 0.87 | 48 | 146 | 97 |
9f | D | C2 | 6 months | 87 | 20 | 13 | 24 | 77 | 0.61 | 0.92 | 0.77 | 46 | 80 | 63 |
11 | D | C2 | 14 months (B) | 78 | 13 | 15 | 25 | 60 | 0.80 | 0.91 | 0.85 | 30 | 61 | 45 |
ASIA impairment scale (AIS) categories for those assessments performed early (1–6) and late (7–11) after injury. Four examinations did not test (NT) upper limbs. Two subjects were taking Baclofen (B) at the time of examination.